Psychometric validation of the female sexual function index (FSFI) in cancer survivors

Cancer

Volumn 118, Issue 18, 2012, Pages 4606-4618

  Baser, Raymond E ^a   Li, Yuelin ^a   Carter, Jeanne ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

physiological; psychological; psychometrics; quality of life; questionnaires; self report; sexual dysfunctions; survivors; women

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVOR; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONSTRUCT VALIDITY; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; FACTORIAL ANALYSIS; FEMALE; FEMALE SEXUAL FUNCTION INDEX; FUNCTIONAL ASSESSMENT; GYNECOLOGIC CANCER; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; SCORING SYSTEM; SELF REPORT; SEXUAL FUNCTION; SEXUALITY; STEM CELL TRANSPLANTATION; UNITED STATES; UTERINE CERVIX CANCER; VALIDATION STUDY;

ADULT; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; PSYCHOMETRICS; QUESTIONNAIRES; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SURVIVORS; WOMEN'S HEALTH;

EID: 84865975290     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26739     Document Type: Article

References (44)

1. Andersen BL, Anderson B, DeProsse C,. Controlled prospective longitudinal study of women with cancer: I. Sexual functioning outcomes. J Consult Clin Psychol. 1989; 57: 683-691.
2. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D,. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2003; 56: 937-949.
3. Carmack-Taylor CL, Basen-Engquist K, Shinn EH, Bodurka DC,. Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol. 2004; 22: 881-889.
4. Lindau ST, Gavrilova N, Anderson D,. Sexual morbidity in very long term survivors of vaginal and cervical cancer: a comparison to national norms. Gynecol Oncol. 2007; 106: 413-418.
5. Jeffery D, Tzeng J, Keefe F, et al. Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee. Cancer. 2009; 115: 1142-1153.
6. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000; 26: 191-208.
7. Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G,. Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scandia. 2002; 81: 443-450.
8. Levin AO, Carpenter KM, Fowler JM, Brothers BM, Andersen BL, Maxwell GL,. Sexual morbidity associated with poorer psychological adjustment among gynecological cancer survivors. Int J Gynecol Cancer. 2010; 20: 461-470.
9. Adelusi B,. Coital function after radiotherapy for carcinoma of the cervix uteri. Br J Obstet Gynaecol. 1980; 87: 821-823.
10. Flay LD, Matthews JHL,. The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys. 1995; 31: 399-404.
11. Meston CM,. Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther. 2003; 29: 39-46.
12. Wiegel M, Meston C, Rosen R,. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005; 31: 1-20.
13. Likes WM, Stegbauer C, Hathaway D, Brown C, Tillmanns T,. Use of the female sexual function index in women with vulvar intraepithelial neoplasia. J Sex Marital Ther. 2006; 32: 255-266.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Revised 4th ed (DMS-IV-TR). Washington, DC: American Psychiatric Association; 2000.
15. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems: Geneva, Switzerland: World Health Organization; 1992.
16. Carter J, Applegarth L, Josephs L, Grill E, Baser RE, Rosenwaks Z,. A cross-sectional cohort study of infertile women awaiting oocyte donation: the emotional, sexual, and quality-of-life impact [serial online]. Fertil Steril. 2011; 95: 711-716.e1.
17. Carter J, Chi DS, Brown CL, et al. Cancer-related infertility in survivorship. Int J Gynecol Cancer. 2010; 20: 2-8.
18. Carter J, Raviv L, Applegarth L, et al. A cross-sectional study of the psychosexual impact of cancer-related infertility in women: third-party reproductive assistance. J Cancer Surviv. 2010; 4: 236-246.
19. Carter J, Sonoda Y, Baser RE, et al. A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. Gynecol Oncol. 2010; 119: 358-365.
20. Frumovitz M, Sun CC, Schover LR, et al. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005; 23: 7428-7436.
21. Schroder MA, Mell LK, Hurteau JA, et al. Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys. 2005; 61: 1078-1086.
22. Tsai TY, Chen SY, Tsai MH, Ho CM, Su YL,. Factors related to sexual dysfunction in patients with cervical cancer [article in Chinese]. Hu Li Za Zhi. 2009; 56: 37-46.
23. Schover LR, Jenkins R, Sui D, Adams JH, Marion MS, Jackson KE,. Randomized trial of peer counseling on reproductive health in African American breast cancer survivors. J Clin Oncol. 2006; 24: 1620-1626.
24. Speer JJ, Hillenberg B, Sugrue DP, et al. Study of sexual functioning determinants in breast cancer survivors. Breast J. 2005; 11: 440-447.
25. Jayne D, Brown J, Thorpe H, Walker J, Quirke P, Guillou P,. Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg. 2005; 92: 1124-1132.
26. Hendren SK, O'Connor BI, Liu M, et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg. 2005; 242: 212.
27. Bhatt A, Nandipati K, Dhar N, et al. Neurovascular preservation in orthotopic cystectomy: impact on female sexual function. Urology. 2006; 67: 742-745.
28. Thirlaway K, Fallowfield L, Cuzick J,. The sexual activity questionnaire: a measure of women's sexual functioning. Qual Life Res. 1996; 5: 81-90.
29. Jensen PT, Klee MC, Thranov I, Groenvold M,. Validation of a questionnaire for self assessment of sexual function and vaginal changes after gynaecological cancer. Psychooncology. 2004; 13: 577-592.
30. Bransfield DD, Horiot JC, Nabid A,. Development of a scale for assessing sexual function after treatment for gynecologic cancer. J Psychosoc Oncol. 1984; 2: 3-19.
31. Monk BJ, Huang HQ, Cella D, Long HJ,. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol. 2005; 23: 4617-4625.
32. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993; 11: 570-579.
33. Ware JE Jr, Kosinski M, Keller SD,. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34: 220-233.
34. Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B,. How to Score Version 2 of the SF-12 Health Survey. Quality Lincoln, RI: Metric Incorporated; 2002.
35. Devins GM, Orme CM, Costello CG, et al. Measuring depressive symptoms in illness populations: psychometric properties of the Center for Epidemiologic Studies Depression (CES-D) scale. Psychol Health. 1988; 2: 139-156.
36. Horowitz M, Wilner N, Alvarez W,. Impact of event scale: a measure of subjective stress. Psychosom Med. 1979; 41: 209-218.
37. Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher B,. Health-related quality of life (HRQL) and tamoxifen in breast cancer prevention. J Clin Oncol. 1999; 17: 2659-2669.
38. Sharpley C, Cross DG,. A psychometric evaluation of the Spanier Dyadic Adjustment Scale. J Marriage Fam. 1982; 44: 739-741.
39. Hunsley J, Pinsent C, Lefebvre M, James-Tanner S, Vito D,. Construct validity of the short forms of the Dyadic Adjustment Scale. Fam Rel. 1995; 44: 231-237.
40. Wenzel L, Dogan-Ates A, Habbal R, et al. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr. 2005; 34: 94-98.
41. Meyer-Bahlburg H, Dolezal C,. The Female Sexual Function Index: a methodological critique and suggestions for improvement. J Sex Marital Ther. 2007; 33: 217-224.
42. Brotto LA,. The Female Sexual Function Index: a methodological critique and suggestions for improvement [letter]. J Sex Marital Ther. 2009; 35: 161-163.
43. Hakstian AR, Whalen TE,. A k-sample significance test for independent alpha coefficients. Psychometrika. 1976; 41: 219-231.
44. Flynn KE, Jeffery DD, Keefe FJ, et al. Sexual functioning along the cancer continuum: focus group results from the Patient Reported Outcomes Measurement Information System (PROMIS). Psychooncology. 2011; 20: 378-386.